Organisational models supported by technology for the management of diabetic disease and its complications in a diabetic clinic setting: study protocol for a randomised controlled trial targeting type 2 diabetes individuals with non-ideal glycaemic values (Telemechron study)
The objective of this study is to evaluate the impact of us ing a digital platform called “TreC Diabete” embedded into a novel organisational asset targeting poorly controlled T2DM individuals in the Autonomous Province of Trento (PAT), Italy.MethodsThis trial was designed as a multi-centre, open-label, randomised, superiority study with two parallel groups and a 1:1 allocation ratio. Individuals regularly attending outpatient diabetes clinics, providing informed consent, are randomised to be prescribed TreC Diabete platform as part of their personalised care plan. Healthcare staff members will remotely assess the data...
Source: Trials - August 10, 2023 Category: Research Source Type: clinical trials
Study on self-management of real-time and individualized support in stroke patients based on resilience: a protocol for a randomized controlled trial
This study uses a randomized controlled trial design to assess the efficacy of using wearable technology to realize real-time and individualized self-management support in stroke patients ’ self-management behavior during the transitional period following discharge from hospital.MethodsThis parallel-group randomized controlled trial will be conducted in two hospitals and patients ’ homes. A total of 183 adult stroke patients will be enrolled in the study and randomly assigned to three groups in a 1:1:1 ratio. The smartwatch intervention group (n = 61) will receive Real-time and Individualized Self-management Suppor...
Source: Trials - August 3, 2023 Category: Research Source Type: clinical trials
Results from Lilly's Landmark Phase 3 Trial of Donanemab Presented at Alzheimer's Association Conference and Published in JAMA
INDIANAPOLIS, July 17, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) presented full results from the Phase 3 TRAILBLAZER-ALZ 2 study showing that donanemab significantly slowed cognitive and functional decline in people with early... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - July 17, 2023 Category: Pharmaceuticals Source Type: clinical trials
Effects of low-dose intravenous heparin therapy in aneurysmal subarachnoid hemorrhage: a randomized controlled clinical trial protocol
This study protocol obtained ethical approval from the Ethics Committee of Baoan People ’s Hospital, Shenzhen, Guangdong (approval number: BYL20220805). This work will be published in peer-reviewed international medical journals and presented at medical conferences.Trial registrationClinicalTrials ID: NCT05696639. Registered on March 30, 2023. (Source: Trials)
Source: Trials - July 8, 2023 Category: Research Source Type: clinical trials
MDT Conferences for People With Diabetes and Multimorbidity
Conditions: Diabetes Mellitus; Comorbidities and Coexisting Conditions Intervention: Sponsors: Odense University Hospital; Steno Diabetes Center Odense Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
